PROTECT Home

Pharmacoepidemiological Research on Outcomes of Therapeutics by a European Consortium

OVERVIEW

The site imi-protect.eu presently has a traffic ranking of zero (the lower the superior). We have parsed nineteen pages within the web page imi-protect.eu and found ten websites interfacing with imi-protect.eu. We were able to find one social media platforms belong to imi-protect.eu.
Pages Parsed
19
Links to this site
10
Social Links
1

IMI-PROTECT.EU TRAFFIC

The site imi-protect.eu is seeing a fluctuation quantities of traffic all over the year.
Traffic for imi-protect.eu

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for imi-protect.eu

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for imi-protect.eu

Date Range

All time
This Year
Last Year
Last Month

LINKS TO WEBSITE

drugis.org Home

ADDIS 2 release 14 improves benefit-risk analysis, both stand-alone and in the main ADDIS app.

ENCePP Home Page

About the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance. Review the list of signals discussed. ENCePP Code of Conduct - Revision 4. The Code also provides for research conduc.

Panacea Pharmacovigilance A better way

Panacea offers end-to-end pharmacovigilance solutions for products at the pre, peri and post-marketing stages of their lifecycle. We monitor the safety profile of medical devices, from the processing and reporting of single adverse incidents through to the removal of products from the market as part of a Field Safety Corrective Action.

SCOPE - Strengthening Collaborations in Operating Pharmacovigilance in Europe

Work Package 2 â Communication and Dissemination. Work Package 3 â Evaluation. Work Package 4 â ADR Collection. Work Package 5 â Signal Management. Work Package 6 â Risk Communications. Work Package 7 â Quality Management Systems. Work Package 8 â Lifecycle Pharmacovigilance. SCOPE Stakeholder event 21 September 2015.

BIFAP Base de datos para la Investigación Farmacoepidemiológica en Atención Primaria

Base de datos para la Investigación Farmacoepidemiológica en Atención Primaria. Solicitud de estudios a BIFAP. Si eres titular de un cupo de medicina general o pediatría del Sistema Nacional de Salud y trabajas en alguna comunidad autónoma que colabore con BIFAP puedes solicitar que tu cupo sea incluido en la base de datos. Si ya has recibido tu contraseña personal en tu cuenta de correo electrónico, inicia sesión para acceder a los servicios BIFAP. 76561939 registros de problemas de salud.

WHAT DOES IMI-PROTECT.EU LOOK LIKE?

Desktop Screenshot of imi-protect.eu Mobile Screenshot of imi-protect.eu Tablet Screenshot of imi-protect.eu

IMI-PROTECT.EU SERVER

We caught that a lone page on imi-protect.eu took four hundred and thirty-five milliseconds to load. We could not observe a SSL certificate, so our crawlers consider imi-protect.eu not secure.
Load time
0.435 sec
SSL
NOT SECURE
IP
195.144.18.87

WEBSITE ICON

SITE TITLE

PROTECT Home

DESCRIPTION

Pharmacoepidemiological Research on Outcomes of Therapeutics by a European Consortium

PARSED CONTENT

The site states the following, "Welcome to the PROTECT website! The latest version of the Adverse Drug Reaction database, updated up to 30 June 2016 in now available on the PROTECT website and can be accessed." I noticed that the web page said " The European Medicines Agency EMA evaluates regulatory impact of PROTECT." They also stated " In the course of this evaluation, a survey tool to measure the public health impact and feasibility of research projects has been developed and piloted. The report is available here. PROTECT WP2 new publications added. Two new publications from WP2 are no." The meta header had Pharmacoepidemiology as the first keyword. This keyword was followed by Pharmacovigilance, Therapeutics, and European Consortium which isn't as important as Pharmacoepidemiology. The other words the site uses is European Risk Management Strategy. independent research is also included and will not be viewed by web crawlers.

SEE MORE WEB PAGES

SAFE-T - The Safer And Faster Evidence-based Translation consortium

Ldquo;SAFE-T Consortium is a unique partnership of the European Pharmaceutical Industry, Academics and Small and Medium Enterprises who are working together to qualify translational safety biomarkers for drug-induced kidney, liver and vascular injury to enable potential new medicines to be evaluated more quickly and safely in patients.

iMi salesmarketing - POS- und Trade-Marketingagentur - iMi salesmarketing

Im Rahmen unseres beliebten Seminarangebotes bieten wir Ihnen auch 2018 wieder Seminare und Workshops mit aktuellen Themen an. Nutzen Sie die Chance zur Wissenserweiterung, profitieren Sie von Best Practice Beispielen und erweitern Sie Ihr Netzwerk mit interessanten Gesprächspartnern. Gewinnspiele, Sammel-, Reichweiten-, Zugabe-Promotions.

Международный институт рынка

Подготовка к ЕГЭ по английскому языку. 380304 Государственное и муниципальное управление. 390303 Организация работы с молодежью. 400201 Право и организация социального обеспечения. 380404 Государственное и муниципальное управление.

IMI - Roosdaal Immaculata Maria-instituut school voor ASO - TSO - BSO onderwijs

Info and inschrijvingen tijdens onze opendeurdag op ZATERDAG 22 APRIL 2017. Is een middelgrote secundaire school voor kwalitatief ASO-BSO-TSO onderwijs. Kapelleweide 5 1760 Roosdaal Tel. 2017 IMI - Roosdaal - Wordpress Theme by Kadence Themes.